• FTC 2nd PBM Report Focuses On Specialty Generics & Steering

  Published On: 01/14/2025

• MA Plan Rate Bump for 2026

  Published On: 01/12/2025

• FDA Anticipates Uptick in Obesity Applications

  Published On: 01/10/2025

• Join Capitol Street in San Francisco during the J.P. Morgan Health Care Conference

  Published On: 01/03/2025

• Blues Plan Restricts Medicines Approved Via Accelerated Approval

  Published On: 01/03/2025

• Three Month CR Moves

  Published On: 12/20/2024

• Budget Showdown: Three Month Extension 

  Published On: 12/19/2024

• Healthcare in CR: Medicare & Commercial PBM Reforms

  Published On: 12/17/2024

• Lame Duck Healthcare: $25 B Package In-Play

  Published On: 12/13/2024

• Polio Vaccine Unlikely to Be Pulled by FDA

  Published On: 12/13/2024

• Lame Duck Healthcare Package: Still Looking Skinny

  Published On: 12/11/2024

• BIOSECURE Not Included in NDAA

  Published On: 12/08/2024

• Reconciliation: Medicaid, MA and More

  Published On: 12/06/2024

• BIOSECURE: Final Sprint for Inclusion in NDAA

  Published On: 12/05/2024

• Cell & Gene Model Update

  Published On: 12/04/2024

• 2026 MA and Part D Rule Re-Cap

  Published On: 12/03/2024

• Medicare Advantage 2026 Rate Outlook

  Published On: 12/02/2024

• Surprise Medicare & Medicaid Obesity Coverage by CMS

  Published On: 11/26/2024

• FDA Nominee Makary Likely to Uphold Safe & Effective Standard

  Published On: 11/24/2024

• FDA’s Digital Health Committee Discusses AI Evaluation Methods

  Published On: 11/22/2024

Previous91011Next